Twist Bioscience CEO Emily M. Leproust sells $51.47 million in shares

Twist Bioscience CEO Emily M. Leproust exercised employee stock options for 208,708 shares and sold 356,546 shares on Sept. 17, 2026, at weighted average prices ranging from $151.46 to $163.39. Her direct holding fell to 620,589 shares.